HistoCyte tissue controls are a testament to precision and reliability in the diagnosis of breast cancer.
There are 4 subtypes of breast cancer based on what antigens they express on the tissues: Hormone receptor-positive (ER/PR), HER2 positive, HER2 low, and triple-negative breast cancer (TNBC)—determining these subtypes through IHC staining guide oncologists for correct patient treatment.
Standardise QC in your breast IHC with our HistoCyte cell-line dynamic range control blocks:
- ER / PR / HER2 Analytes
- Breast Analyte (ER, PR, HER2)
- PD-L1 Analyte
Breast Analyte ControlDR
For high-sensitivity testing with only 1 block, no more changing control blocks per IHC stain. The cell microarray blocks contain 5 key cores: ER, PR, HER2, and a triple negative core.
| Cell line | IHC HER2 | IHC ER | IHC PR |
| A: Osteosarcoma | 0 | Negative | Negative |
| B: Breast Adenocarcinoma | 0 | Homogeneous positive | Heterogeneously positive |
| C: Breast Ductal Carcinoma | 1+ | Heterogeneously positive | Homogeneous positive |
| D: Breast Ductal Carcinoma | 1+/2+ | Heterogeneously positive | Heterogeneously positive |
| E: Breast Ductal Carcinoma | 3+ | Heterogeneously positive | Heterogeneously positive |
PD-L1 Analyte Control DR
For dynamic range testing for breast and other PD-L1 cancer types. The cell microarray blocks contain 4 key cores: 3 different PD-L1 cell lines, and PD-L1 negative core.
| Cell line | PD-L1 |
| A: Breast Ductal Carcinoma |
Negative |
| B: Osteosarcoma |
Low |
| C: Fibrosarcoma | Medium |
| D: T-cell non-Hodgkin Lymphoma | High |
Learn more about HistoCyte
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
